FOUNDERS GROVE WEALTH PARTNERS, LLC

Position in ABBV — AbbVie Inc.

CIK 2046157 RICHMOND, VA

Position in ABBV

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$739,569

+$135,165 QoQ

Shares Held

2,939

+5.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

#2,832

of 4,153 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

FOUNDERS GROVE WEALTH PARTNERS, LLC holds $22,439,048 across 6 Drug Manufacturers - General names. ABBV ranks #3 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	15,366	$18,430,442
2	JNJ	Johnson & Johnson	8,327	$2,114,808
3	ABBV	AbbVie Inc. This page	2,939	$739,569
4	MRK	Merck & Co., Inc.	4,961	$637,488
5	GILD	Gilead Sciences, Inc.	2,346	$296,393
6	NVS	Novartis AG	1,406	$220,348

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$739,569	2,939	+5.8%	Shares	Sole	2026-07-22
2026-03-31	$604,404	2,779	+4.7%	Shares	Sole	2026-04-15
2025-12-31	$606,412	2,654	+7.3%	Shares	Sole	2026-01-12
2025-09-30	$572,598	2,473	+3.6%	Shares	Sole	2025-10-17
2025-06-30	$443,074	2,387	+0.3%	Shares	Sole	2025-07-28
2025-03-31	$498,657	2,380	0.0%	Shares	Sole	2025-04-16
2024-12-31	$422,926	2,380	—	Shares	Sole	2025-01-14
No filing history on record for this holder in this stock.